The Procter & Gamble Company
PG · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.61 | -6.10 | -1.43 | 1.21 |
| FCF Yield | 1.12% | 1.02% | 0.71% | 0.99% |
| EV / EBITDA | 57.09 | 76.42 | 76.34 | 61.66 |
| Quality | ||||
| ROIC | 4.58% | 3.53% | 3.76% | 4.66% |
| Gross Margin | 51.37% | 49.11% | 50.98% | 52.39% |
| Cash Conversion Ratio | 1.13 | 1.37 | 0.98 | 1.04 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.66% | 0.92% | 1.20% | 1.66% |
| Free Cash Flow Growth | 5.49% | 40.16% | -27.03% | 17.86% |
| Safety | ||||
| Net Debt / EBITDA | 3.54 | 4.75 | 4.49 | 3.60 |
| Interest Coverage | 29.73 | 20.54 | 21.00 | 23.92 |
| Efficiency | ||||
| Inventory Turnover | 1.39 | 1.41 | 1.31 | 1.48 |
| Cash Conversion Cycle | -38.08 | -38.34 | -38.09 | -38.94 |